Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Heart rate variability and heart rate turbulence in HIV-infected patients receiving combination antiretroviral therapy.

Wongcharoen W, Khienprasit K, Phrommintikul A, Sukonthasarn A, Chattipakorn N.

Ann Noninvasive Electrocardiol. 2013 Sep;18(5):450-6. doi: 10.1111/anec.12064. Epub 2013 Jun 9.

PMID:
24047489
2.

QT dispersion in HIV-infected patients receiving combined antiretroviral therapy.

Wongcharoen W, Suaklin S, Tantisirivit N, Phrommintikul A, Chattipakorn N.

Ann Noninvasive Electrocardiol. 2014 Nov;19(6):561-6. doi: 10.1111/anec.12162. Epub 2014 Apr 21.

PMID:
24750179
3.

Decreased heart rate variability in HIV positive patients receiving antiretroviral therapy: importance of blood glucose and cholesterol.

Askgaard G, Kristoffersen US, Mehlsen J, Kronborg G, Kjaer A, Lebech AM.

PLoS One. 2011;6(5):e20196. doi: 10.1371/journal.pone.0020196. Epub 2011 May 31.

4.

Heart rate variability and heart rate turbulence in patients with hematologic malignancies subjected to high-dose chemotherapy in the course of hematopoietic stem cell transplantation.

Poręba M, Poręba R, Gać P, Usnarska-Zubkiewicz L, Pilecki W, Piotrowicz E, Piotrowicz R, Rusiecki L, Kuliczkowski K, Mazur G, Sobieszczańska M.

Ann Noninvasive Electrocardiol. 2014 Mar;19(2):157-65. doi: 10.1111/anec.12108. Epub 2013 Nov 8.

PMID:
24206437
5.

Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate variability.

Lebech AM, Kristoffersen US, Mehlsen J, Wiinberg N, Petersen CL, Hesse B, Gerstoft J, Kjaer A.

Clin Physiol Funct Imaging. 2007 Nov;27(6):363-7.

PMID:
17944658
6.

Influence of heavy cigarette smoking on heart rate variability and heart rate turbulence parameters.

Cagirci G, Cay S, Karakurt O, Eryasar N, Kaya V, Canga A, Yesilay AB, Kilic H, Topaloglu S, Aras D, Demir AD, Akdemir R.

Ann Noninvasive Electrocardiol. 2009 Oct;14(4):327-32. doi: 10.1111/j.1542-474X.2009.00321.x.

PMID:
19804508
7.
8.

Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.

McComsey G, Bhumbra N, Ma JF, Rathore M, Alvarez A; First Pediatric Switch Study..

Pediatrics. 2003 Mar;111(3):e275-81.

PMID:
12612284
9.

Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy.

Lainka E, Oezbek S, Falck M, Ndagijimana J, Niehues T.

Pediatrics. 2002 Nov;110(5):e56.

PMID:
12415062
10.

Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.

Moreno-Torres A, Domingo P, Pujol J, Blanco-Vaca F, Arroyo JA, Sambeat MA.

Antivir Ther. 2007;12(2):195-203.

PMID:
17503662
11.

Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia.

Lu CL, Lin YH, Wong WW, Lin HH, Ho MW, Wang NC, Hsieh SM, Sheng WH, Hung CC, Chen MY.

J Microbiol Immunol Infect. 2011 Aug;44(4):258-64. doi: 10.1016/j.jmii.2010.08.003. Epub 2011 Jan 20.

12.

Heart rate variability and heart rate turbulence in hypothyroidism before and after treatment.

Celik A, Aytan P, Dursun H, Koc F, Ozbek K, Sagcan M, Kadi H, Ceyhan K, Onalan O, Onrat E.

Ann Noninvasive Electrocardiol. 2011 Oct;16(4):344-50. doi: 10.1111/j.1542-474X.2011.00461.x.

PMID:
22008489
13.

The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.

Nachman S, Gona P, Dankner W, Weinberg A, Yogev R, Gershon A, Rathore M, Read JS, Huang S, Elgie C, Hudgens K, Hughes W.

Pediatrics. 2005 Apr;115(4):e488-94. Epub 2005 Mar 16.

PMID:
15772172
14.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677
15.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
16.

Power spectral analysis of heart rate variability in HIV-infected and AIDS patients.

Correia D, Rodrigues De Resende LA, Molina RJ, Ferreira BD, Colombari F, Barbosa CJ, Da Silva VJ, Prata A.

Pacing Clin Electrophysiol. 2006 Jan;29(1):53-8.

PMID:
16441718
17.

European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy.

Guzmán-Fulgencio M, Berenguer J, Micheloud D, Fernández-Rodríguez A, García-Álvarez M, Jiménez-Sousa MA, Bellón JM, Campos Y, Cosín J, Aldámiz-Echevarría T, Catalán P, López JC, Resino S.

J Antimicrob Chemother. 2013 Oct;68(10):2349-57. doi: 10.1093/jac/dkt206. Epub 2013 Jun 7.

PMID:
23749950
18.

Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features.

Counihan PJ, Fei L, Bashir Y, Farrell TG, Haywood GA, McKenna WJ.

Circulation. 1993 Oct;88(4 Pt 1):1682-90.

PMID:
8403313
19.

Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.

Cassol E, Malfeld S, Mahasha P, Bond R, Slavik T, Seebregts C, Poli G, Cassol S, van der Merwe SW, Rossouw T.

J Infect Dis. 2013 Oct 1;208(7):1113-22. doi: 10.1093/infdis/jit249. Epub 2013 Jun 6.

PMID:
23749968
20.

Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.

Chaix ML, Seng R, Frange P, Tran L, Avettand-Fenoël V, Ghosn J, Reynes J, Yazdanpanah Y, Raffi F, Goujard C, Rouzioux C, Meyer L; ANRS PRIMO Cohort Study Group..

Clin Infect Dis. 2013 Mar;56(6):880-7. doi: 10.1093/cid/cis999. Epub 2012 Dec 7.

PMID:
23223603

Supplemental Content

Support Center